Powerful AIsolutions for cancerpathology diagnostic support
AI-based cancer pathology image analysis solutions Available with & without DeepDx Viewer
2 Products
Products under development
2 Products
-
Metastasis to nearby lymph nodes significantly impacts the prognosis of breast cancer. We are developing a new algorithm that analyzes the WSI of Sentinel Lymph Nodes to locate small patches of metastases hidden in expansive regions of normal tissue.
Breast Sentinel Lymph Node (SLN)
-
The newest addition to the DeepDx product line, this algorithm identifies and highlights cancerous areas in WSIs of biopsy specimens obtained from TURBT (Trans Urethral Resection of Bladder Tumor)
Bladder
Advanced deep learning technology to provide unmatched performance
Core Technology that sets us apart
Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.
world-class patents in:
-
01
Deep learning-based diagnostics
technology -
02
Diagnostic result visualization
technology -
03
Tissue slide indexing technology
-
04
Intelligent annotation technology
Awards & Recognition
-
- Edison Awards - Silver
- DeepDx Prostate won Silver at the Edison Award 2021 in the Cellular Research & Disease Prevention category.
-
- Camelyon17 Grand Challenge
- Our research team won the first place in Camelyon17, a global image analysis competition for detection and classification of breast cancer lymph nodes metastasis.
R&D for innovation in medical AI
-
AI-based Predictive Analytics
in Cancer Pathology - Development of prediction models by combining cancer pathology image analysis with oncology clinical data
- Treatment
- DeepDx Prostate is CE-marked, and MFDS-approved for clinical use in Korea. DeepDx solutions are not cleared by the FDA and for Research Use Only (RUO) in the United States. Contact Deep Bio for more information on system configuration, functionality and indications for use.